ESR1 and breast cancer: These conflicting results show that cell-dependent effects of estradiol do not depend solely on ERα expression; however, increased ERα expression can enhance anti-estrogen chemosensitivity such as to TAM, which is a beneficial change in hormone-resistant breast cancer cells that may apply to future clinical trials.